Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: Is ribavirin harmful? [3]

Blood

Volumn 107, Issue 8, 2006, Pages 3409-3410

  Balestrieri, Cinzia ^b   Serra, Giancarlo ^b   Cauli, Cristiana ^b   Chessa, Luchino ^b   Balestrieri, Angelo ^b   Farci, Patrizia ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; DRUG SAFETY; ENZYME ACTIVITY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT WITHDRAWAL;

EID: 33645745996     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-11-4508     Document Type: Letter

References (7)

1. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-982.
2. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958-965.
3. Sulkowski MS, Wasserman R, Brooks L, Ball L, Gish R. Changes in haemoglobin during interferon alfa-2b plus ribavirin combination therapy for chronic hepatitis C viral infection. J Viral Hepat. 2004;11:243-250.
4. McHutchison JG, Manns M, Patel K, et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology. 2002;123:1061-1069.
5. Grattagliano I, Russmann S, Palmieri VO, et al. Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C. Hepatology. 2004;39:1248-1255.
6. Betke K, Beutler E, Brewer GJ, et al. Standardization of procedures for the study of glucose-6-phosphate dehydrogenase: report of a WHO scientific group. WHO Tech Rep Ser. 1967;366:1-53.
7. Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN. International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol. 1979;43:465-467.